Bedell Frazier Investment Counselling’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.9M Buy
12,980
+99
+0.8% +$100K 2.41% 8
2025
Q4
$13.8M Buy
12,881
+3,042
+31% +$2.91M 2.67% 6
2025
Q3
$7.51M Buy
9,839
+198
+2% +$147K 1.54% 23
2025
Q2
$7.52M Buy
9,641
+5,390
+127% +$4.19M 1.89% 19
2025
Q1
$3.51M Buy
4,251
+102
+2% +$84.9K 0.89% 35
2024
Q4
$3.2M Buy
4,149
+48
+1% +$39.7K 0.79% 38
2024
Q3
$3.63M Buy
4,101
+45
+1% +$40.5K 0.87% 37
2024
Q2
$3.67M Buy
4,056
+2
+0% +$1.6K 0.89% 40
2024
Q1
$3.15M Buy
4,054
+22
+0.5% +$15.7K 0.79% 40
2023
Q4
$2.35M Buy
4,032
+1,459
+57% +$852K 0.65% 38
2023
Q3
$1.38M Sell
2,573
-500
-16% -$258K 0.41% 48
2023
Q2
$1.44M Sell
3,073
-27
-0.9% -$11.3K 0.42% 48
2023
Q1
$1.06M Hold
3,100
0.31% 50
2022
Q4
$1.13M Hold
3,100
0.3% 54
2022
Q3
$1M Hold
3,100
0.28% 53
2022
Q2
$1M Hold
3,100
0.31% 47
2022
Q1
$888K Hold
3,100
0.22% 54
2021
Q4
$856K Hold
3,100
0.21% 62
2021
Q3
$716K Hold
3,100
0.2% 57
2021
Q2
$711K Hold
3,100
0.18% 63
2021
Q1
$579K Sell
3,100
-927
-23% -$181K 0.16% 60
2020
Q4
$680K Hold
4,027
0.21% 57
2020
Q3
$596K Hold
4,027
0.21% 54
2020
Q2
$661K Hold
4,027
0.27% 46
2020
Q1
$559K Hold
4,027
0.26% 40
2019
Q4
$450K Hold
4,027
0.18% 39
2019
Q3
$450K Sell
4,027
-2,000
-33% -$223K 0.18% 41
2019
Q2
$668K Buy
6,027
+2,000
+50% +$236K 0.24% 38
2019
Q1
$523K Buy
+4,027
New +$490K 0.21% 42

Other funds holding LLY

Bedell Frazier Investment Counselling's LLY Position: Q1 2026 in Review

Bedell Frazier Investment Counselling increased its Eli Lilly (LLY) stake by 0.77% in Q1 2026, buying an estimated $100K and bringing the position to 12,980 shares worth $11.9M. The position accounts for 2.41% of the portfolio, ranked #8.

Bedell Frazier Investment Counselling first reported a position in LLY in Q1 2019 and has held it in 29 quarters since. The position peaked at $13.8M in Q4 2025. 4,364 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bedell Frazier Investment Counselling held 12,980 shares of Eli Lilly worth $11.9M as of Q1 2026.
  • Bedell Frazier Investment Counselling bought 99 Eli Lilly shares in Q1 2026, an estimated $100K.
  • Eli Lilly made up 2.41% of Bedell Frazier Investment Counselling's portfolio in Q1 2026, its #8 holding.
  • Bedell Frazier Investment Counselling first reported a position in Eli Lilly in Q1 2019 and has held it in 29 quarters since.
  • Bedell Frazier Investment Counselling's Eli Lilly position peaked at $13.8M in Q4 2025.
  • 4,364 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bedell Frazier Investment Counselling's 13F filing for Q1 2026, filed 15 May 2026.